Skip to content
Trial Eligibility
Menu

Lung Cancer Clinical Trials near Houston, TX

217 studies for Lung Cancer are recruiting at 324 sites within 50 miles of Houston, Texas, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Lung Cancer trials in the US or all trials near Houston.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Lung Cancer studies enrolling near Houston

Showing the 50 nearest of 217 studies.
  1. A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

    NCT07144280

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Texas Oncology - Gulf Coast (Houston, TX); The University of Texas MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    15 sites within 50 mi
  2. This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

    NCT06758401

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: The University of Texas MD Anderson Cancer Center Clinical Research Imaging (Houston, TX); The University of Texas MD Anderson Cancer Center Diagnostic Imaging (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    12 sites within 50 mi
  3. Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

    NCT04181060

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Houston Methodist Hospital (Houston, TX); Houston Methodist West Hospital (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  4. Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

    NCT07222566

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Texas Oncology - Gulf Coast (Houston, TX); Texas Oncology - Gulf Coast (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  5. Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

    NCT05624996

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center (Houston, TX); Ben Taub General Hospital (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  6. Study of PF-07248144 in Advanced or Metastatic Solid Tumors

    NCT04606446

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: MD Anderson West Houston (Houston, TX); The University of Texas M. D. Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  7. Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

    NCT07226999

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Texas Oncology - Gulf Coast (Houston, TX); Texas Oncology - Gulf Coast (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  8. Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

    NCT04267848

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Houston Methodist Hospital (Houston, TX); Houston Methodist West Hospital (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  9. A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

    NCT06623422

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Houston Methodist Cancer Center ( Site 0191) (Houston, TX); MD Anderson Cancer Center ( Site 0150) (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  10. A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

    NCT07090499

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: The University of Texas, MD Anderson Cancer Center - West Houston (Houston, TX); University of Texas MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  11. A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

    NCT06119581

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Houston Methodist Hospital (Houston, TX); Lumi Research (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  12. A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

    NCT06667076

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: MD Anderson Cancer Center (Houston, TX); Oncology Consultants Texas (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  13. Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

    NCT06890598

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Houston Methodist Hospital (Houston, TX); University of Texas MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  14. A Study of Sigvotatug Vedotin in Advanced Solid Tumors

    NCT04389632

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Oncology Consultants, PA (Houston, TX); Oncology Consultants, PA. (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  15. A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

    NCT06793215

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: The University of Texas MD Anderson Cancer Center (Houston, TX); Community Clinical Trials (Kingwood, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  16. Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

    NCT07227298

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Lumi Research (Houston, TX); Southwest Oncology Associates (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  17. Couple-Based Meditation for Metastatic Lung Cancer Patients and Their Partners

    NCT02596490

    • Interventional
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: Memorial Hermann (Houston, TX); University of Texas MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  18. A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

    NCT05208762

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: The University of Texas MD Anderson Cancer Center (Houston, TX); The University of Texas MD Anderson Cancer Center Investigational Pharmacy Services (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  19. A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

    NCT05669430

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Oncology Consultants, P.A. (Houston, TX); The University of Texas M. D. Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  20. A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

    NCT05920356

    • Phase 3
    • Ages 18 to 100 years
    • Sex: All

    Nearest sites: Oncology Consultants PA (Houston, TX); University of Texas MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  21. Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

    NCT05983432

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Oncology Consultants, P.A. (Houston, TX); University of Texas M.D. Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  22. A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

    NCT06203210

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Houston Methodist Cancer Center (Houston, TX); University of Texas Md Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  23. Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

    NCT06218914

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site (Houston, TX); Research Site (Galveston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  24. A Study of MGC026 in Participants With Advanced Solid Tumors

    NCT06242470

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: The University of Texas MD Anderson Cancer Center (Houston, TX); University of Texas Health Science Center at Houston (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  25. A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

    NCT06270706

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: NEXT Houston (Houston, TX); University of Texas MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  26. A Study of IBI363 in Subjects with Advanced Solid Malignancies

    NCT06281678

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: MD Anderson Cancer Center-University of Texas (Houston, TX); Oncology Consultants P.A. (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  27. Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

    NCT06350097

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site (Houston, TX); Research Site (Webster, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  28. Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

    NCT06357533

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site (Houston, TX); Research Site (Kingwood, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  29. Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

    NCT06422143

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Memorial Hermann Cancer Center ( Site 0015) (Houston, TX); Oncology Consultants P.A. ( Site 0124) (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  30. Pan-tumor MRD Study

    NCT06605404

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Onocology Consultants P.A. (Oncology Consultants [OC Houston]) (Houston, TX); Community Clinical Trials (Kingwood, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  31. Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

    NCT06712355

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: The University of Texas MD Anderson Cancer Center (Houston, TX); Texas Oncology Cancer Center (Sugar Land, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  32. Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

    NCT06767514

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Clinical Study Site (Houston, TX); Clinical Study Site (Webster, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  33. Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

    NCT06881784

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: MD Anderson Cancer Center (Houston, TX); Texas Oncology - Gulf Coast (The Woodlands, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  34. Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

    NCT06899126

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: University of Texas M. D. Anderson Cancer Center (Houston, TX); Lumi Research (Kingwood, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  35. Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

    NCT07080242

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: MD Anderson Cancer Center (Houston, TX); NEXT Houston (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  36. A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

    NCT07154290

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: The University of Texas MD Anderson Cancer Center (Houston, TX); University of Texas Medical Branch (Galveston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  37. A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

    NCT07174583

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Oncology Consultants, PA- Houston (Houston, TX); The University of Texas MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  38. A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

    NCT07277413

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: MD Anderson (Houston, TX); NEXT Oncology Houston (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  39. A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

    NCT07361510

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Kelsey-Seybold Clinic Main Campus (Houston, TX); University Of Texas Medical Branch At Galveston (Galveston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  40. Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

    NCT07397338

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: MD Anderson Cancer Center (Houston, TX); MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  41. A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

    NCT07503808

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: MD Anderson (Houston, TX); NEXT Texas LLC - Houston (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  42. Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

    NCT00991094

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: M D Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  43. Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

    NCT02984761

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: Michael E. DeBakey VA Medical Center, Houston, TX (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  44. A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

    NCT03093116

    • Phase 1/2
    • Ages 12 years and older
    • Sex: All

    Nearest site: MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  45. Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoing Stereotactic Body Radiation Therapy for Lung Cancer

    NCT03422302

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: M D Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  46. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest site: Massive Bio SYNERGY-AI site (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  47. A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

    NCT03526835

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Oncology Consultants (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  48. VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

    NCT03556228

    • Phase 1/2
    • Ages 18 to 80 years
    • Sex: All

    Nearest site: The University of Texas MD Anderson Cancer Center (site 127) (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  49. Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors

    NCT03740256

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Baylor St. Luke's Medical Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  50. Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

    NCT03819296

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: M D Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Lung Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.